Company intelligence / Profile preview

Darnitsa

Ownership: Private
Employees: ~1100
Development stage: Commercial

Overview

Darnitsa has a broad commercial portfolio of over 180 products with a focus on cardiology, neurology and pain management. It was the first Ukrainian company licensed to produce Pfizer’s oral COVID‑19 treatment for low/middle-income countries and has begun acquiring technology for mRNA-based vaccines. The company continues to launch new products even during wartime disruptions.

No specific clinical trial results are published as the company primarily produces generics and established medicines.

Therapeutic areas: CardiovascularNeurologyInfectious Diseases
Modalities: small molecules (tablets, ampoules, sterile antibiotics)oral antivirals (e.g., nirmatrelvir/ritonavir)potential mRNA-based vaccines in development
Industry: Biotech

Drug pipeline

3 assets

Neospastil

2 more assets in the full pipeline.

Request access →

Partnerships

Medicines Patent Pool/Pfizer for generic nirmatrelvir/ritonavir productionWorld Health Organization for mRNA vaccine technology transfer

Beyond the preview

Go deeper on Darnitsa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Darnitsa.

Explore the full profile